More tools:Markets·Screener·Research·Chat

Evolent Health, Inc Class A Common Stock (EVH) Financial Statements

Evolent Health, Inc Class A Common Stock
SIC 8741 · SERVICES-MANAGEMENT SERVICES
FIGI BBG005CHLMB3
XNYS · usd
4.22▼ 0.10 (-2.31%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close4.32
Day's Range4.06 – 4.35
52-Week Range2.09 – 10.08
Volume2.3M
Avg Volume3.1M
Share Statistics
Shares Outstanding
Employees4,200
ExchangeXNYS
Listed2015-06-05
Share count as of August 1, 2026
Loading Income Statement…
Key questions about Evolent Health, Inc Class A Common Stock (EVH)
What is Evolent Health, Inc Class A Common Stock's Market Cap?
Evolent Health, Inc Class A Common Stock's Market Cap is $477.1M, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's Enterprise Value?
Evolent Health, Inc Class A Common Stock's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's Price / Sales?
Evolent Health, Inc Class A Common Stock's Price / Sales is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's EV / Revenue?
Evolent Health, Inc Class A Common Stock's EV / Revenue is 0.6×, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's EV / EBITDA?
Evolent Health, Inc Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's Revenue (TTM)?
Evolent Health, Inc Class A Common Stock's Revenue (TTM) is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's Net Income (TTM)?
Evolent Health, Inc Class A Common Stock's Net Income (TTM) is -$511.1M, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's EBITDA?
Evolent Health, Inc Class A Common Stock's EBITDA is -$315.7M, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's Diluted EPS (TTM)?
Evolent Health, Inc Class A Common Stock's Diluted EPS (TTM) is -4.52, based on as-reported figures from SEC (XBRL) filings.
What is Evolent Health, Inc Class A Common Stock's EBITDA Margin?
Evolent Health, Inc Class A Common Stock's EBITDA Margin is -15.1%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+46.9%+2.6%-27.5%-22.8%
Expenses
Cost of revenue
Selling, general and administrative expenses
Depreciation and amortization expenses
Loss on lease termination
Change in fair value of contingent consideration
Operating expenses
% of revenue101.5%102.1%187.1%99.8%
Operating loss
% of revenue-1.5%-2.1%-87.1%0.2%
Interest income
Interest expense
Gain (loss) from equity method investees
Loss on option exercise
Extinguishment of Series A Preferred Stock and other refinancing fees—
Other income (expense), net
Loss before income taxes
Provision for (benefit from) income taxes
Income (loss) before preferred dividends and accretion of Series A Preferred Stock
% of revenue-4.3%-5.4%-91.6%-4.4%
Dividends and accretion of Series A Preferred Stock
Net loss attributable to common shareholders of Evolent Health, Inc. - basic
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted
Basic (in dollars per share)
Diluted (in dollars per share)